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Abstract 
 
Focal cartilage defects (FCD) of the knee joint remain a difficult area of treatment for 
orthopaedic surgeons, as they often progress to generalized osteoarthritis (OA). 
Osteochondral autograft transfer (OAT) to the damaged cartilage area has shown 
promise, but this has been associated with pain and bleeding at the site of graft harvest. 
The use of mesenchymal stem cells (MSCs) in a matrix to regenerate articular cartilage 
has been proposed. This work describes a prospective case-control series comparing 
OAT with a novel, MSC-seeded scaffold graft in the stifle joints of healthy merino sheep. 
The triphasic grafts were composed of a beta-tricalcium phosphate osseous phase, an 
intermediate activated plasma phase and a collagen I hydrogel cartilage phase.  
The osseous and cartilage phases were seeded with autologous MSCs.  
All sheep underwent creation of a full-thickness, 4.0 mm diameter FCD (n=20) followed 
by six weeks of unrestricted activity, allowing the defects to degenerate naturally. At six 
weeks, half of the lesions were treated with OAT and half with the triphasic engineered 
grafts.  
At 6-month and 12-month follow-up, no significant differences were noted between 
groups with regard to overall histological scores. Macroscopic and biomechanical 
analysis at 12 months showed no significant differences between groups. In summary, 
autologous MSC-seeded implants showed comparable repair quality to OAT without the 
associated donor site morbidity. 
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III. Foreword 
 
This dissertation uses the cumulative form of promotion, as the related publication 
appeared in the Journal of Orthopaedic Research in December 2010. This publication, 
which includes the background, methods, results and discussion of the experimental 
data, is included in this work. 
 
Publication details: 
 
Marquass B1, Somerson JS1, Hepp P, Aigner T, Schwan S, Bader A, Josten C., 
Zscharnack M, Schulz RM. A novel MSC-seeded triphasic construct for the repair of 
osteochondral defects. Journal of Orthopaedic Research. 2010 Dec; 28(12): 1586-99. 
1These authors contributed equally to the work. 
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1. Introduction 
  Injuries to the articular cartilage represent an area of medicine in which current 
therapies cannot fully restore a joint to a native, pre-injury state. For this reason, 
new treatment modalities are necessary to prevent these injuries from progressing 
to osteoarthritis (OA), a disease state that substantially restricts health-related 
quality of life and employment capacity.  
  Current options for treatment include techniques that stimulate the underlying bone 
below the cartilage layer to produce new tissue, transplantation of existing tissue 
into the defect, joint replacement using conventional prostheses and implantation of 
engineered tissue into the defect. The limitations of each of these approaches will be 
discussed in brief, followed by a review of the osteochondral tissue-engineering 
approach used in the present work and opportunities for future development. 
 
1.1 Epidemiology and clinical background  
  Focal cartilage defects (FCDs) are a frequent cause of disability and functional 
limitations. A review of over 30,000 knee arthroscopies identified FCDs in 63% of 
patients, with an average of 2.7 lesions per patient (Curl et al., 1997). In the acute 
phase, these injuries cause substantial limitations and reductions in quality of life, 
with objective clinical scores similar to those of patients with end-stage arthritis (Heir 
et al., 2010). A high economic burden from absenteeism and work-related disability 
has also been demonstrated (Lindahl et al., 2014). Of additional concern is the 
potential for focal lesions to develop into generalized OA. FCDs have a limited 
potential for spontaneous healing given the poor vascular supply and hypocellularity 
of joint cartilage (O’Driscoll, 1998). As a result, these injuries have the potential to 
initiate a degenerative cascade with progressive development of OA.  
  A longitudinal study demonstrated increased cartilage loss in healthy adults with 
existing FCDs, indicating that the presence of these defects is a risk factor for 
degenerative joint disease (Cicuttini et al., 2005). The burden of disease and poor 
prognosis without treatment have led to development of numerous surgical 
management strategies. 
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1.2 Marrow-stimulating techniques 
  In response to lack of vascularity in articular cartilage, surgeons have developed 
various techniques that seek to bring blood supply to the damaged cartilage by 
penetrating subchondral bone. These techniques are grouped under the term 
“marrow-stimulating techniques”, as they share the goal of recruiting marrow-based 
stem cells to the repair site (see Figure 1). The mechanism of this technique has 
recently been shown to involve chondroinduction with collagen II deposition in the 
deep and middle cartilage zones (Hoemann et al., 2015). Early animal studies in 
large and small animal models demonstrated the need to penetrate the subchondral 
bone to obtain defect coverage with fibrocartilage tissue (Kim et al., 1991; Vachon et 
al., 1986). The technique in most common use today is microfracture, in which the 
defect area is treated with penetration of subchondral bone using small hand-held 
picks in an arthroscopic procedure (Steadman et al., 1997). A recent systematic 
review of Level I and II studies demonstrated good short-term results of 
microfracture for small lesions, but worsening outcomes after two to five years 
(Goyal et al., 2013). Despite this, the widespread use of microfracture in clinical 
practice as well as the low cost and simplicity of the procedure make it a commonly 
used gold standard by which other cartilage repair techniques are measured. 
Modifications to this method include the addition of a matrix material to the site of 
microfracture to better contain the released marrow elements, a practice known as 
autologous matrix-induced chondrogenesis (AMIC) (Behrens, 2005).  
  Clinical trials have shown superior cartilage repair quality at one and five year follow-
up with AMIC compared to standard microfracture, but no difference in clinical 
scores has been demonstrated (Shive et al., 2015; Stanish et al., 2013). 
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Figure 1: Microfracture technique. (A) Debridement of margins, (B) Removal of calcified 
cartilage layer, (C) Perforation of subchondral bone, (D) Resulting mesenchymal clot (Figure 
taken from Mithoefer et al., 2006). 
 
1.3 Autologous chondrocyte or stem cell implantation 
  Autologous chondrocyte implantation (ACI) was initially described in the 1990s as a 
method for harvesting cartilage tissue, expanding the harvested chondrocytes, and 
injecting the cultured cells into cartilage defects under a periosteal membrane as 
shown in Figure 2 (Brittberg et al., 1994). Long-term case series using this method 
have demonstrated significant improvements in functional outcome scores at five to 
twenty years after implantation (Beris et al., 2012; Minas et al., 2013; Peterson et al., 
2010). Comparison of ACI to OAT in a prospective randomized trial demonstrated a 
lower failure rate at long-term follow-up in the ACI group (17%) compared to OAT 
(55%) (Bentley et al., 2012). 
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  More recently, researchers have implanted the harvested cells after seeding them 
onto a collagen matrix, giving rise to the name “matrix-associated autologous 
chondrocyte implantation”, or MACI (Bartlett et al., 2005). The superiority of the 
matrix technique over the standard periosteal membrane technique has not been 
demonstrated in randomized controlled trials (Gooding et al., 2006, p. 20; Zeifang et 
al., 2010). Although ACI/MACI has the recommendation of the German Society of 
Orthopaedic Surgery and Traumatology (DGOU) for focal cartilage injuries larger 
than 3-4 cm2 (Niemeyer et al., 2013), significant negative aspects of the technique 
include a two-stage surgery in order to harvest graft tissue, the expense of 
chondrocyte culture and a high rate of reoperation due to hypertrophy of the graft in 
periosteal techniques (Richter et al., 2015). 
Figure 2: Intraoperative image of a focal cartilage defect treated with first-generation 
autologous chondrocyte implantation (Figure taken from Mithoefer et al., 2012). 
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1.4 Osteochondral autograft transfer 
  The principle of OAT involves harvest of one or more osteochondral grafts from non-
weight-bearing portions of the knee and transfer into weight-bearing defect regions 
as shown in Figure 3. Hangody et al. coined the term “mosaicplasty” to describe the 
practice of shaping multiple autografts to fill a single defect (Hangody et al., 1997).  
A report of 831 patients undergoing mosaicplasty reported good-to-excellent results 
in 92% of patients (Hangody and Füles, 2003). However, a systematic review 
comparing OAT to microfracture demonstrated no significant differences in activity 
levels, functional outcome scores, or cost-efficacy (Miller et al., 2015). The OAT 
technique may cause morbidity at the donor site where the plugs are harvested, 
which also limits the size of defects that can be repaired (LaPrade and Botker, 
2004). In order to avoid this, researchers have sought other approaches including 
osteochondral tissue-engineered scaffolds. 
Figure 3: Clinical example of a large cartilage defect treated with osteochondral allograft 
transfer (Figure taken from Kock et al., 2011). 
 
1.5 Osteochondral tissue-engineered scaffolds 
  To mimic the native layers of cartilage and subchondral bone found in the knee, 
multilayer synthetic scaffolds have been developed and tested in preclinical animal 
models. These scaffolds can be seeded with chondrocytes or mesenchymal stem 
cells (MSCs) to promote regeneration of healthy cartilage tissue (Caplan and 
Goldberg, 1999). The layers of these scaffolds are composed of materials designed 
to replicate the mechanical and biological qualities of cartilage and bone. For the 
cartilage layer, materials have included polyethylene glycol (PEG) (Alhadlaq and 
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Mao, 2005), calcium polyphosphate (Kandel et al., 2006), hyaluronic acid (Ahn et al., 
2009; Kon et al., 2014; Miot et al., 2012), chitosan-gelatin (Chen et al., 2011), 
chondroitin sulfate/hyaluronic acid/gelatin (Deng et al., 2014) as well as collagen 
(Kon et al., 2010; Schleicher et al., 2013). Of these, type 1 collagen (col1) was 
chosen for the present study given its mechanical properties and ability to allow 
MSC adhesion (Zhang et al., 2013).  
  With regard to the subchondral osseous phase, a material must be chosen with 
adequate initial mechanical strength, good cell ingrowth properties and integration 
with native surrounding bone (Shimomura et al., 2014). Researchers have reported 
on cell-seeded osseous materials including hyaluronic acid/chitosan/gelatin (Chen et 
al., 2011), ceramic bovine bone/gelatin (Deng et al., 2014) as well as beta-tricalcium 
phosphate (TCP) (Mellor et al., 2015; Meng et al., 2014; Seo et al., 2015). The 
observed quality of TCP to resorb and be replaced by native bone makes it an 
excellent choice for tissue-engineering approaches seeking to restore native 
anatomy (Artzi et al., 2004). 
 
1.6 Cartilage restoration approaches with mesenchymal stem cells 
  MSCs have shown great promise for cartilage regeneration techniques for a variety 
of reasons. For one, MSCs can be pre-differentiated prior to implantation to direct 
them to a chondrocyte lineage, as has been reported by several pre-clinical studies 
(Lam et al., 2014; Lee et al., 2015; Marquass et al., 2011; Spaas et al., 2015; Tang 
et al., 2015; Zscharnack et al., 2010). In contrast to chondrocytes, which 
dedifferentiate with culture expansion, MSCs treated with predifferentiation 
accumulate cartilage-specific matrix properties after implantation (Rackwitz et al., 
2014). Contaminating hematopoietic cells and heterogeneity of MSCs isolated from 
bone marrow has been a concern, but advances in isolation, selection and culture 
methods have resulted in efficient and homogeneous cell populations (Baustian et 
al., 2015). Finally, the immune-privileged status of MSCs creates the possibility of 
off-the-shelf allogeneic transplantation of cells, uncoupling the cell source from the 
patients who are treated (Smith et al., 2015). This approach has been supported 
clinically by a study demonstrating regeneration of meniscus tissue and no adverse 
immune effects with injection of allogeneic MSCs into the knee joint (Vangsness et 
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al., 2014).  
 
1.7 Clinical applications of cell-seeded osteochondral scaffolds to date 
  Studies using cell-seeded bilayer scaffolds in small animal model have showed good 
formation of regenerated tissue and integration between the graft and surrounding 
native cartilage (Gao et al., 2002; Lam et al., 2014). However, based on the 
International Cartilage Repair Society (ICRS) guidelines for preclinical testing of 
cartilage repair techniques, larger animal models such as goat, sheep or horse are 
recommended for pivotal studies (Hurtig et al., 2011). These results have been 
replicated in large animal models with mid-term follow-up (Kandel et al., 2006; Kon 
et al., 2010). A recent study using scaffolds made of poly(lactic-co-glycolic acid) 
(PLGA) seeded with MSCs showed good quality of cartilage regeneration in a sheep 
model at 12 months, with better results seen in MSC-seeded scaffolds compared to 
those seeded with mature cartilage cells (Caminal et al., 2015).  
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1.8. Aim of the dissertation 
  Despite many advances in the field of cartilage repair, there remains a need for a 
technique that is single-stage, cost-effective and provides reliable long-term 
outcomes (Richter et al., 2015). To this end, further large animal studies are needed 
prior to clinical experimentation in humans. Use of a tissue-engineered 
osteochondral implant seeded with MSCs obtained from bone marrow aspiration 
was chosen as a potential answer to the problems of donor site morbidity and 
surface area limitations of OAT techniques. 
  A cooperative project between the Department of Orthopedics, Plastic Surgery and 
Traumatology at the University Clinic of Leipzig  and the Translational Center for 
Regenerative Medicine at the University of Leipzig was initiated to compare two 
methods of repair of chronic, critical-size focal cartilage lesions in a sheep model: (1) 
repair using an OAT and (2) repair using a tissue-engineered triphasic construct 
consisting of a TCP osseous phase, an intermediate activated plasma phase and a 
collagen I hydrogel phase. Outcomes were determined based on validated 
histological scoring systems at six and twelve months. The study was performed 
after obtaining authorization from the local legal representative for animal studies. 
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2. Publication 
 
A Novel MSC-Seeded Triphasic Construct for the Repair of
Osteochondral Defects
B. Marquass,1,6 J.S. Somerson,1,8 P. Hepp,1 T. Aigner,3 S. Schwan,4,5 A. Bader,6 C. Josten,1 M. Zscharnack,2,6 R.M. Schulz2,6
1Department of Trauma and Reconstructive Surgery, University of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany, 2Translational Centre for
Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany, 3Department of Pathology, University of Leipzig, Liebigstrasse 26, 04103
Leipzig, Germany, 4Fraunhofer Institute for Mechanics of Materials IWM, Biological and Biocompatible Materials, Walter-Hu¨lse-Str. 1, 06120
Halle/Saale, Germany, 5Karlsruhe Institute of Technology, Institute for Reliability of Components and Systems, Kaiserstraße 12, 76131 Karlsruhe,
Germany, 6Center of Biotechnology and Biomedicine, Department of Cell Techniques and Applied Stem Cell Biology, University of Leipzig,
Deutscher Platz 5a, 04103 Leipzig, Germany
Received 27 October 2009; accepted 22 March 2010
Published online 18 May 2010 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/jor.21173
ABSTRACT: Mesenchymal stem cells (MSC) are increasingly replacing chondrocytes in tissue engineering based research for treatment
of osteochondral defects. The aim of this work was to determine whether repair of critical-size chronic osteochondral defects in an ovine
model using MSC-seeded triphasic constructs would show results comparable to osteochondral autografting (OATS). Triphasic implants
were engineered using a beta-tricalcium phosphate osseous phase, an intermediate activated plasma phase, and a collagen I hydrogel
chondral phase. Autologous MSCs were used to seed the implants, with chondrogenic predifferentiation of the cells used in the cartilage
phase. Osteochondral defects of 4.0mm diameter were created bilaterally in ovine knees (n=10). Six weeks later, half of the lesions were
treated with OATS and half with triphasic constructs. The knees were dissected at 6 or 12 months. With the chosen study design we
were not able to demonstrate significant differences between the histological scores of both groups. Subcategory analysis of O’Driscoll
scores showed superior cartilage bonding in the 6-month triphasic group compared to the autograft group. The 12-month autograft group
showed superior cartilage matrix morphology compared to the 12-month triphasic group. Macroscopic and biomechanical analysis showed
no significant differences at 12 months. Autologous MSC-seeded triphasic implants showed comparable repair quality to osteochondral
autografts in terms of histology and biomechanical testing. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
J. Orthop. Res. 28: 1586–1599, 2010
Keywords: cartilage; osteoarthritis; osteochondral autografting; animal model; mesenchymal stem cells
Localized articular cartilage defects are frequently
encountered by practicing orthopedic surgeons, but
their proper treatment remains a controversial subject.
It is widely held that cartilage lesions larger than a
critical size result in an increased risk of progression
to osteoarthritis (OA).1 Osteochondral autograft tech-
niques such as the Osteochondral Autograft Transfer
System (OATS) or mosaicplasty are used in clinical
practice for repair of localized femoral condyle cartilage
lesions and have shown good long-term results.2,3 How-
ever, this method presents a number of limitations. For
one, morbidity at the donor site limits the size of defects
that can be repaired to an optimal maximum size of
1–4 cm2.4 Post-operative symptoms related to the donor
site such as persistent pain have been reported by sev-
eral authors.5−7 Donor site bleeding has been implicated
as a cause of early hemarthrosis.4,8 In addition, the sur-
gical difficulty of shaping host tissue to fit the defect area
is a limiting factor.9 Inadequate bonding of the graft car-
tilage to surrounding tissue is a common finding noted
in second-look arthroscopy in clinical subjects10 as well
as histological analysis in animal models.11,12
Synthetic tissue-engineered multiphasic implants
consisting of distinct cartilage and bone layers are an
area of increasing research interest. This treatment
Correspondence to: B. Marquass (T: 49-3419717845; F: 49-
3419717309.; E-mail: bastian.marquass@medizin.uni-leipzig.de)
© 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
method has the potential to restore the anatomical
osteochondral junction without iatrogenic injury at
donor sites and with the flexibility to treat larger
lesions.13 Biphasic structures cultivated with autolo-
gous osteogenic and/or chondrogenic cells have shown
promising results in vitro.14−16 The majority of in vivo
studies investigating multiphasic scaffolds have been
performed on small animal models.17−20 Kandel et
al.21 investigated biphasic constructs in a sheep model
showing in vivo results after 9 months. This study
suggests that biphasic constructs may be suitable to
repair joint defects. However, this study used autolo-
gous chondrocytes for the cartilage layer instead of bone
marrow-derived MSCs. In addition, nearly all of this
research is done on a model of acute cartilage injury
in which generation of a defect is immediately followed
by repair in a single surgery. To more accurately model
the chronic cartilage damage seen in human subjects
undergoing cartilage repair, use of a chronic injury
model may be more appropriate.22 Based on superior
in vivo results for MSC-seeded constructs in compar-
ison to chondrocyte-seeded implants23 and due to the
demonstrated osteogenic and chondrogenic potential
of MSCs,15,18,24−28 we developed a new MSC-based
triphasic construct. The objective of this study was to
compare the clinically established OATS technique with
triphasic MSC-seeded implants for treatment of chronic
osteochondral defects. We hypothesized that repair
of critical-size chronic osteochondral defects using
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MSC-seeded triphasic constructs would show cartilage
properties comparable to osteochondral autografting as
well as good integration of the osseous phase. To the
best of the authors’ knowledge, no prior studies showing
12-month results of MSC-based multiphasic cartilage
repair in a chronic large animal defect model have been
published.
MATERIALS AND METHODS
A complete description of the methodology used in this study
can be found in Appendix A.
Animals
Ten skeletally mature and healthy female merino sheep with
an age of 2–2.5 years and an average weight of 65kg (57–75kg)
were used for this study. The sheep were randomly divided
into two groups with follow-ups of 6 and 12 months. The
right hind knee of each sheep was treated with a triphasic
scaffold and the left knee was treated with an osteochondral
autograft. The animals were treated in accordance with appli-
cable animal protection laws (Paragraph 8, Section 1) and
authorization by the local legal representative was granted
(TVV/07).
Bone Marrow Aspiration and Triphasic Implant Production
Prior to the first surgery, bonemarrow aspirates were obtained
from each sheep and MSCs were isolated and expanded for
4 weeks to passage one. Venous blood was also collected
from each sheep and autologous EDTA plasma and serum
were isolated. For the chondral phase, 4.0×105 MSCs/mL
were mixed with a clinically approved collagen type I hydro-
gel (CaReS®, Arthro Kinetics Biotechnology, Krems, Austria)
and cultured for 14 days in a chondrogenic medium (Chon-
drogenic Bullet Kit®, Lonza, Cambridge) with 10ng/mL
TGF-!3. Simultaneously, 1×106 MSCs were mixed with
autologous EDTA plasma and 0.1M CaCl2 and seeded onto
resorbable !-TCP implants (CERASORB®, Curasan, Kleinos-
theim, Germany) with a diameter of 6mm and length
of 10mm. The cylinders contained four parallel-oriented,
vertical macropores with a diameter of 1mm, resulting
in a true porosity of 65%. The osseous constructs were
then cultured for 14 days in autologous expansion medium
(Fig. 1).
In Vitro Analysis of Constructs
The viability of the MSCs in both composites was determined
following culture using fluorometric live/dead staining. Gene
expression profiles of the chondral constructs were deter-
mined using RT-PCR with primers as shown in Table 1 of
Appendix A. Scanning electron microscopy (SEM) was per-
formed to confirm cell morphology and distribution on the
constructs. Immunohistochemistry of cryosections of the chon-
dral phase was performed for aggrecan and collagen type II
(Fig. 1).
Surgical Techniques
In the primary surgery, bilateral full-thickness defects with
a diameter of 4mm were created to 2mm below the calci-
fied layer in the medial femoral condyles of the sheep using a
medial arthrotomy (Fig. 2A). After 6 weeks, the animals were
returned for a second surgery with implantation of the con-
structs. The original arthrotomy was reopened and the initial
defects (Fig. 2B) were cored out using a 6.4mm harvesting
drill to a depth of 12mm. In the right knee, an MSC-seeded
JOURNAL OF ORTHOPAEDIC RESEARCH DECEMBER 2010
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Figure 1. Overview of triphasic implant production.
!-TCP cylinder was inserted (Fig. 2C). Autologous cancellous
bone taken from the harvested cylinder was used to fill the
200"m gap between the !-TCP cylinder and the surround-
ing native bone. The intermediate activated autologous plasma
phasewas applied and a seeded collagen I gel phasewas affixed
and fitted to the condyle surface (Fig. 2D). In the left knee,
the patella was released medially and laterally subluxated to
allow for harvest of an osteochondral cylinder of 6.6mm in
diameter and 12mm depth. The cylinder was implanted using
a press-fit technique. After 6 or 12 months, the hind knees
were explanted for analysis of regeneration. Each sample was
first visually graded by a specialist orthopedist using the Brit-
tberg ICRS Visual Scale.29,30 This scale assesses the degree of
defect repair, integration to the border zone and macroscopic
surface appearancewith a rating of 0–4,where 4 represents the
best appearance. After biomechanical analysis of the samples
using a ball indentation test, the samples underwent plastina-
tion for preparation of histological slides. Toluidine blue31 and
Levai–Laczko32,33 stains were used. The slides were graded
independently by three reviewers using the ICRSVisualHisto-
logical Scale,34 the O’Driscoll Scale35 and the semiquantitative
Siebert score.36
High-resolution micro-computed tomography ("CT) scans
were made of all triphasic constructs (La ThetaTM LCT-100,
Aloka, Inc., Tokyo, Japan). The slice thickness was set to
0.1mm. Measurements of the sinking distance of the !-TCP
cylinders were then made using computer software (ImageJ,
NIH, Bethesda, MD) by drawing a tangent to the subchon-
dral bone surface and measuring perpedicular from this to the
highest point on the !-TCP cylinder.
Statistics
For assessment of statistical significance, non-parametric
Mann–Whitney U tests were done using SPSS (SPSS, Inc.,
Chicago, IL). Statistical significance was set at p<0.05.
RESULTS
See Appendix B for cell viability and extracellular
marker accumulation/expression results.
Assessment of Tissue Regeneration
Macroscopy
Visual evaluation according to the ICRS Brittberg
score revealed significantly higher scoring in terms of
“macroscopic appearance” (OATS 6 months: 2.6±0.6,
12 months: 2.8±1.1; triphasic 6 months: 1.4±0.6, 12
months: 2.0±0.7) and “degree of defect repair” (OATS
6 months: 4.0±0.0, 12 months: 3.8±0.5; triphasic 6
months: 3.2±0.8, 12 months: 3.2±1.3) for the OATS
group after 6 months (Fig. 3A and B). At 12 months
the OATS group showed higher values for both param-
eters without being statistically significant. Nearly no
difference in terms of “bonding to adjacent cartilage”
was observed macroscopically at 6 and 12 months.
Histological Analysis
ICRS Visual Histological Scale
We found no statistical differences in overall scores
between the OATS and triphasic groups after 6 and 12
Figure 2. Implantation of triphasic construct. (A) Fresh defect immediately after creation. (B) Chronic defect at re-arthrotomy after 6
weeks. (C) Osseous phase with visible !-TCP cylinder. (D) Chondral phase after implantation.
JOURNAL OF ORTHOPAEDIC RESEARCH DECEMBER 2010
Dissertation   Jeremy S. Somerson 
 
 
 
12 
 
TRIPHASIC CONSTRUCT FOR OSTEOCHONDRAL REPAIR 1589
Figure 3. Macroscopic views after 6 months of OATS (A), triphasic (B), and repair tissue at donor site (C).
Figure 4. Histology of triphasic construct repair tissue (Levai–Laczko stain). (A) Sinking of the osseous construct with incomplete
subchondral bone coverage (6-month specimen, 500!m bar). (B) Complete subchondral bone coverage (12-month specimen, 500!m bar).
(C) Five times magnification of rectangle shown in (B) (100!m bar).
Figure 5. Histology of OATS specimens (Levai–Laczko stain). (A) Severe cyst formation was noted in this 6-month specimen (500!m
bar). Arrows indicate original osteochondral implant borders. (B) 12-month specimen with incomplete cartilage bonding (500!m bar) and
(C): 5× magnification of rectangle shown in (B) (100!m bar).
months using the ICRS scale (Figs. 4–6). Analyzing the
subcategories individually, we observed significantly
higher scores in the OATS group for “matrix composi-
tion,” “cell distribution,” and “cell population” after 12
months (Fig. 7). O’Driscoll score: No significant differ-
ences between the total scores of the two groups could
be observed (Fig. 8 and Table 1). As with ICRS scoring,
we found significant differences here in “cell morphol-
ogy” with higher values for the OATS group after 6
and 12 months. “Bonding to adjacent cartilage” was
significantly better for triphasic implants than auto-
grafts after 6 months but not after 12 months. Within
the triphasic group, the repair tissue showed signifi-
cantly higher “toluidine blue staining” after 12 months
than after 6 months. Within the OATS group, better
“structural integrity” for the cylinder was observed
after 1 year compared to the results after 6 months.
In addition, less degenerative changes were found
after 12 months. Siebert Semiquantitative Score: Total
scores and subcategory scores showed no significant
differences between the two groups at either endpoint.
Although “bonding to adjacent cartilage” was greater
in the triphasic implants at 6 months (OATS: 0.7±0.6;
triphasic: 1.5±0.5), this difference was not statisti-
cally significant (p=0.071). For the triphasic group we
observed higher scores (p<0.01) for “subchondral recon-
struction” after 1 year (3.2±0.7) compared to 6 months
(0.8±1.0) (Figs. 4–8, Table 1).
Figure 6. Histology of triphasic specimen (A). Magnification of the same triphasic (B) and OATS (C) histology (Levai–Laczko stain) at
5× showing the native/regenerated cartilage border. Native cartilage is seen on the left in (B) and (C).
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Figure 7. ICRS visual histological score by subcategories showing 2× standard error (2SE). Differences of statistical significance are
marked with the * symbol.
Figure 8. O’Driscoll score, group totals showing 2× standard
error (2SE).
Biomechanical Testing
Indentation forces showed no significant differences
between the 6-month triphasic (0.09±0.04N) and
OATS (0.15±0.10N) groups or between the 12-month
triphasic (0.15±0.02N) and OATS (0.11±0.05N)
groups (Fig. 9). One measurement from the 12-month
triphasic group was not included in the analysis
due to a technical error. Significantly (p<0.047)
softer repair tissue in comparison to native cartilage
(0.16±0.04N) was measured for the 6-month tripha-
sic group (0.09±0.04N). At 12 months, no statistically
significant difference between triphasic regenerated
cartilage and native cartilage (0.13±0.03N) was
observed.
Micro-CT
Measurements revealed that in total four triphasic
implants were sunken more than 3mm below the sub-
chondral bone plate. The average distance between the
tip of the !-TCP implant and the subchondral bone was
2.6mm after 6 months and 2.4mm after 12 months.
DISCUSSION
The concept of a triphasic scaffold arose fromexperimen-
tation with MSC-seeded matrix-associated autologous
chondrocyte implantation (MACI) methods for repair of
osteochondral defects that showed frequent dislocation
Figure 9. Ball indentation test showing 2× standard error (2SE).
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of the cartilage matrix and subchondral cavity forma-
tion. In response to this, an MSC-seeded osseous phase
was added to provide subchondral stability and an inter-
mediate activated plasma layer was used for fixation. In
addition, an experimental study showed superior results
with in vivo cartilage repair when prior in vitro chon-
drogenic differentiation was induced.37 Based on these
findings, this study describes a novel triphasic construct
for repair of deep osteochondral defects using a collagen
I scaffold seeded with chondrogenically differentiated
MSCs, an intermediate layer of autologous plasma and
a porous, seeded !-TCP cylinder. This implant was
compared to the clinically established OATS technique
using a validated large animal model for degenerated
critical-size cartilage defects.22 In contrast to our first
hypothesis, the OATS group did appear to have supe-
rior cartilage matrix morphology. However, histological
analysis showed generally similar results between the
osteochondral autograft and triphasic groups, as no
significant differences were observed in the total sum
of any of the 3 histological scores used for analysis.
The superior cartilage bonding to adjacent native tis-
sue seen in the 6-month triphasic group was a notable
finding given the well-known issue of incomplete carti-
lage bonding in osteochondral autografts.10−12 It further
demonstrates the capacity of MSCs to differentiate into
various tissues38 and the ability ofMSCs to achieve good
bonding to surrounding native cartilage.39 Additional
longer-term studies are required here to chart the course
of repair provided by these implants.
Our second hypothesis was that the autografts and
!-TCP implants would both show good bone integra-
tion. For the !-TCP implants, we even noted significant
resorption of the implant and ingrowth of trabecu-
lar bone. This supports the good biocompatibility of
the implants, a concern presented by a previous study
examining non-porous calcium phosphate scaffolds.40
On the other hand, sinking of the !-TCP cylinders
more than 3mm into the underlying bone was noted
in 4 of the 10 samples with accompanying new forma-
tion of a subchondral bone layer above the cylinder, a
phenomenon that was not observed in the autograft
groups. MSCs have osteogenic potential, particularly
in combination with osteosupportive material, such as
hydroxyapatite/!-TCP.41 If this bony overgrowth were
derived from the MSCs seeded onto the !-TCP implant,
one would assume a more polydirectional growth pat-
tern originating from the !-TCP. Instead of this, we
observed overgrowth from the cylinder’s rim. Thus the
new bone formation does not appear to originate within
the !-TCP implant, but rather appears to grow from
the subchondral bone at both sides of the defect zone
until the implant is covered. This is in accordance with
a study performed by Petersen et al.,40 which showed
sinking of an implant with accompanying bone over-
growth. The regeneration of the subchondral layer over
time is in line with similar long-term studies.40,42 In
another study, Guo et al.43 published results of carti-
lage repair using MSC-seeded !-TCP scaffolds, but did
not report any sinking or dislocation of the implants.
One possible explanation is that a defect depth of 4mm
measured from the cartilage surface was used. Assum-
ing a cartilage thickness of 1.5mmand a further 1–2mm
for the calcified layer and subchondral bone plate,44 the
implants might not have been as deep inside the can-
cellous bone, allowing for superior fixation. Given the
relative softness of the cancellous femoral condyle in
comparison to the rigid subchondral bone plate, one
might assume that under weight-bearing, the rigid
!-TCP implant is pushed deeper into the cancellous
bone. Comparable mean sinking values after 6 and 12
months indicate that this process most probably occurs
in the early post-implantation phase. Pulliainen et al.45
reported sinking of PLDLA scaffolds and attributed
this to impact on the joint surface causing cracks in
the subchondral bone. This effect might also be related
to the implantation technique used for the triphasic
implants, which may not have provided the same imme-
diate retention force as the press-fit implantation of
the OATS cylinders. Further studies in which post-
operative weight-bearing can be limited are needed to
confirm this and MRI imaging of gross joints with in
situ implants could provide more precise, quantifiable
information.
Some possible shortcomings of the OATS method
were also seen in our research. In 7 of the 10 autografts,
subchondral peri-implant cyst formation was seen in
histological analysis (Fig. 5A). This did not always corre-
latewith the surface appearance of the cartilage, and the
functional significance of this finding is unclear. How-
ever, reports of this in other animal model studies of
osteochondral autografts lead us to believe that this is
not an isolated occurrence.46,47 We also noticed severe
degeneration at the donor sites with incomplete tissue
filling and substantial bone exposure (Fig. 3C). Although
the significance of donor site morbidity remains a con-
troversial topic, the poor healing response noted in this
study would seem to correlate well with previous find-
ings of poor tissue quality and postoperative pain. Use
of a more extensive arthrotomy including patellar lux-
ation for the OATS method is one factor that requires
discussion. After plug transfer, the medial retinaculum
was reconstructed and patellar tracking was tested to
ensure normal alignment. Harvesting the osteochon-
dral plug from the medial trochlea is a commonly used
method, but this requires patellar luxation. Althoughwe
cannot be certain that this did not influence our final
outcome, we feel that the following points make this
unlikely. First, the animals were clinically observed two
times a day in the early postoperative periodwith regard
to wound healing and effusion. We found no differ-
ences between both knees, indicating that no additional
hematoma or bleeding was present in the OATS-treated
knees. Furthermore, no postoperative patellar luxation
occurred. At the time of harvest, a normal gait pattern
was observed in all animals. Third, the defect on the
medial condyle was in the load-bearing area influenced
by vertical load. Even if instability or lateralization of
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the patella would have been present, an effect on plug
healing would be unlikely. Another point to discuss in
this regard is the potential for different load-bearing in
the hind limbs. We did not measure the load-bearing,
which is a limitation of the study design. However the
defects were created and later treated in the same size
and location on both sides. By operating on both knees
at the same time, unloading of one leg was difficult
to obtain for the animal, thus ensuring similar load-
bearing of both knees. Further limitations of this study
included the small sample size used, which was lim-
ited by experimental board approval. The data obtained
from this study will allow for accurate power analysis
in future studies and provide support for larger sam-
ple groups. We did observe a high level of variability in
the quality of repair tissue, as can be seen in the stan-
dard deviations of histological scores. Further studies
should also include control groups such as microfrac-
ture or untreated defects for comparison with more
widespread treatment modalities. Additional endpoints
such as in vivo radiographs or MRI imaging, gait analy-
sis and ROM testing could lend clinical relevance to this
treatment modality.
In general, these findings indicate that the MSC-
seeded triphasic implants used here cannot be consid-
ered as a superior treatment option due to the observed
sinking phenomenon of triphasic implants and high
variability in the results of the repair tissue. How-
ever, good osseointegration of the MSC-seeded !-TCP
implants and superior bonding of MSC-assisted car-
tilage repair were observed. Based on these results,
further studies should investigate superior implant
fixation into subchondral bone. More basic research
regarding the integration of the chondral and osseous
phases as well as animal studies with a larger sample
size will also be necessary before clinical applications
can be developed.
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APPENDIX A: MATERIALS AND METHODS
Isolation and Cultivation of Ovine MSCs
Prior to the first surgery, bone marrow aspirates
of 20–40mL were obtained from the iliac crest of
each sheep. Mononuclear cells were isolated from the
heparinized aspirates (500 IU [3.125"g/mL] per mL;
Ratiopharm, Ulm, Germany) by Ficoll density gradient
centrifugation (density 1.077 g/mL; Biochrom, Berlin,
Germany) and plated at 2×104 cells/cm2 in tissue cul-
ture flasks with Dulbecco’s modified Eagle’s medium
(DMEM; Gibco, Karlsruhe, Germany) supplemented
with 10% autologous serum, 100U/mL penicillin, and
100"g/mL streptomycin (both Biochrom), referred to
below as autologous expansion medium. Cultures were
maintained at 37◦C in a humidified atmosphere contain-
ing 95% air and 5% O2 to 5% CO2 balanced with N2
in a tri-gas incubator (Thermo Fisher Scientific, Dreie-
ich, Germany).Mediumwas changed twiceweekly. After
10–14 days, the cells were detached using trypsin/EDTA
(0.25%/0.05mM; Biochrom), passaged at 5,000 cells/cm2
and cultured to reach 80–90% confluence of passage one
(P1) before collagen I gel and !-TCP-cylinder prepara-
tion.
Isolation of Autologous Serum
Venous blood (100mL) was collected from each sheep
by puncturing the veins of both ears using S-Monovette
blood withdrawal systems containing coagulation acti-
vator (Sarstedt, Nu¨mbrecht, Germany). Themonovettes
were centrifuged for 10min at 2,500g and 20◦C. The
serum phase was harvested and inactivated by heat
(56◦C, 30min).
Isolation of Autologous Plasma
For autogenic plasma and fibrin glue production, 18mL
of venous blood was obtained aseptically from each ani-
mal using S-monovettes containing EDTA (Sarstedt).
The collected EDTA/whole blood mixture was processed
to plasma by centrifuging at 2,500g for 10min at 20◦C
and removing the plasma fraction. The prepared plasma
was transferred into 2mL cryo tubes and stored at
−80◦C until seeding of the !-TCP cylinder with MSCs
and the implantation procedure.
Implant Preparation (Fig. 1)
Preparation and Cultivation of the Chondral Phase
For preparation of the chondral phase, 4.0×
105 MSCs/mL were mixed with a clinically approved
collagen type I hydrogel (CaReS®, Arthro Kinet-
ics Biotechnology) according to the manufacturer’s
instructions. For each construct, an aliquot of 1.8mL
cell–gel-suspension were transferred to 12-well plates
(BD Falcon, Heidelberg, Germany) and cultured 14
days with serum-free, chondrogenic medium (Chondro-
genic Differentiation BulletKit®) supplemented with
10ng/mL TGF-!3 (both Lonza, Wuppertal, Germany).
The differentiation was performed at 20% pO2 (Thermo
Fisher Scientific). The chondrogenic medium was
changed twice weekly (Fig. 1).
Preparation and Cultivation of the Osseous Phase
Resorbable pure-phase !-TCP CERASORB® cylinders
with a diameter of 6mm and length of 10mm were
supplied as a gift from Curasan. The cylinders were
seeded with 1×106 MSCs of P1 and cultured for 14
days in autologous expansion medium. Per cylinder,
1×106 cells were mixed in 100"L thawed autologous
plasma and 1"L of 0.8MCaCl2 was added to achieve fib-
rin polymerization with a clotting reaction. The !-TCP
ceramic cylinders were then soaked in a 96-well plate
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with this mixture, transferred into separate wells of a
24-well plate filled with 1mL of autologous expansion
medium (see above), and incubated at 37◦C, 95% rel-
ative humidity in an air/5% CO2 atmosphere (Thermo
Fisher Scientific). Medium was changed twice weekly.
Each culture condition was carried out in triplicate.
Determination of Cell Viability
The viability of the MSCs in both composites was deter-
mined following culture by a fluorometric live/dead
stainingmethod (Mobitec, Goettingen,Germany), which
allowed for quantification of the cellular uptake of
calcein AM and ethidiumhomodimer. After taking out
both scaffolds from the well plates, the constructs were
washed with 5mLPBS for 2h each and afterwards incu-
bated with fluorometric assay components for 30min.
The excitation and detection wavelengths were 515 and
635nm respectively.
Total RNA Extraction, cDNA Synthesis, and RT-PCR
Gene expression profiles of chondral constructs were
evaluated by using RT-PCR in a Primus 96 Plus PCR
machine (MWG Biotech, Ebersberg, Germany). Two to
three gels were digested with 2mg/mL collagenase A
solution (Roche, Basel, Switzerland) for 2 h at 37◦C and
resuspended in RLT lysis buffer (Qiagen, Hilden, Ger-
many). Total RNA was purified using the RNeasy Mini
Kit (Qiagen). Digestion of DNAwas performed by apply-
ing 2U RQ1-DNAse (Promega, Mannheim, Germany)
at 37◦C for 30min. RNA concentration and purity were
measured with a NanoDrop spectrophotometer (Peqlab,
Erlangen, Germany) at 260 and 280nm. Single-strand
cDNA copies were generated from 1!g samples of total
purified RNA by using random primers and M-MLV
reverse transcriptase (both Promega) according to the
manufacturer’s protocol.
The prepared MasterMIX contained 10× PCR buffer,
25mM MgCl2, 0.5U Taq polymerase (Qiagen), 8mm
dNTPmix (Fermentas, St. Leon-Rot, Germany) and
10mm of sequence specific primers (Table A1; Operon
Biotechnologies, Cologne, Germany). PCR reactions con-
dition were as follows: 95◦C for 5min/95◦C for 30 s,
annealing for 30 s, 72◦C for 30 s, and final extension at
72◦C for 5min. All samples were normalized with the
housekeeping gene glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH).
Scanning Electron Microscopy
Constructs for scanning electron microscopy (SEM)
were rinsed with Sorenson’s buffer (pH 7.2) and
immersed and fixed at 4◦C in 2% glutaraldehyde pre-
pared in Sorenson’s buffer for 2 h. Scaffolds were rinsed
in Sorenson’s buffer and postfixed in 1% osmium tetrox-
ide (Plano, Marburg, Germany) for 2h. Scaffolds were
rinsed again and dehydrated in acetone series, dried in
Critical Point Dryer CPD30 (Baltec, Tucson, AZ) sputter
coated with platinum and examined in a Hitachi S4500
scanning electron microscope (Finchampstead, UK).
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Immunohistochemistry
Immunohistochemistry of cryosections was performed
using the two-step indirect method. The samples were
embedded in Tissue Tek® (Sakura, Zoeterwoude, the
Netherlands) sectioned at a thickness of 8!m by a
Leica CM3050S cryotome (Leica Microsystems, Nuss-
loch, Deutschland). The sections were fixed for 5min in
acetone, blocked for 30min (sheep serum 1:10 diluted in
PBS) and incubated with the primary antibody (colla-
gen type II: mousemonoclonal antibody [Clone: II-4C11;
MP Biomedicals, Solon, OH], diluted 1:2,000 in PBS;
aggrecan:monoclonalmouse antibody [AcrisAntibodies,
Herford, Germany], diluted 1:50 in PBS). After washing
with PBS, the secondary antibody of peroxidase-
conjugated goat-anti-mouse IgG (Jackson ImmunoRe-
search, Cambridgeshire, UK; diluted 1:50 in PBS) was
added for 1h at 37◦C. Immunostaining was developed
by 3-amino-9-ethyl-carbazol substrate. Cell nuclei were
counterstained with Meyer’s hematoxylin (Lillie’s Mod-
ification; DakoCytomation, Hamburg, Germany).
Surgical Techniques
Defect Application
Following bone marrow aspiration and blood draw, an
initial operation was performed to create bilateral full-
thickness osteochondral defects in the medial femoral
condyles of the sheep. Preoperative sedation, orotra-
cheal intubation, and anesthesia were performed under
supervision of a veterinarian. Arthrotomy of the hind
knee joints was performed using a medial arthrotomy
under standard sterile conditions. The defects were cre-
ated with a diameter of 4mm and a depth of 2mm
below the calcified layer using a custom depth-limited
drill (Aesculap, Tuttlingen, Germany). The sheep were
then returned to the herd for degeneration of the defects.
Regular post-operative wound checks were performed.
Triphasic Construct Implantation
After 6 weeks, the animals were returned to the labo-
ratory for implantation of the constructs. The primary
arthrotomy was reopened in standard fashion to expose
the chronic lesions, all of which were noted to be grade 4
on the Brittberg ICRS Visual Scale. The initial defect
was cored out using a 6.4mm harvesting drill to a
depth of 12mm and the defect cylinder was removed
using a graft harvester (Zimmer, Winterthur, Switzer-
land). The MSC-seeded "-TCP cylinder was inserted
using a press-fit technique. The intermediate autolo-
gous plasma phase was then activated using CaCl2 and
applied to the surface of the cylinder. The seeded colla-
gen I hydrogel phase was affixed onto the plasma layer
and fitted to the condyle surface using an impactor (Zim-
mer). The joint capsule and wound were then closed in
standard layer-by-layer fashion.
Osteochondral Autograft Transplantation
Surgery continued on the contralateral side and the
defect was removed with a coring drill as previously
described. The patella was released medially and later-
ally subluxated using an extended parapatellar incision.
A 6.6mmdiameter and 12mmdeep osteochondral cylin-
der was then harvested from the medial facet of the
trochlea. The cylinder was implanted with a press-fit
technique into the condylar defect crater using SDS
instruments. After plug transfer, the medial retinac-
ulum was reconstructed using Vicryl 2-0 sutures and
patellar tracking was tested to ensure normal align-
ment.
Explantation
The hind knees were then dissected at 6 or 12 months
for analysis of regeneration. A diamond band saw (E310,
Exakt ApparatebauGmbH,Norderstedt, Germany) was
used to cut blocks containing each defect region of
approximately 1 cm in diameter and 3 cm in depth from
the femurs of the sheep. The blocks were cut perpendic-
ular to the articular surface. All samples were initially
placed in PBS prior to biomechanical testing and trans-
ferred to formaldehyde at 24h post-explantation.
Macroscopic Analysis
Prior to further evaluation, each sample was visually
graded by a specialist orthopedic surgeon according to
the Brittberg ICRS Visual Scale (Table A2).29,30 This
Table A2. ICRS Visual Scale29,30
Points
I: Degree of defect repair
In level with surrounding cartilage 4
75% repair of defect depth 3
50% repair of defect depth 2
25% repair of defect depth 1
0% repair of defect depth 0
II: Integration to border zone
Complete integration with
surrounding cartilage
4
Demarcating border <1mm 3
3/4th of graft integrated, 1/4th with
a notable border >1mm width
2
1/2 of graft integrated with
surrounding cartilage, 1/2 with a
notable border >1mm
1
From no contact to 1/4th of graft
integrated with surrounding
cartilage
0
III: Macroscopic appearance
Intact smooth surface 4
Fibrillated surface 3
Small, scattered fissures, or cracks 2
Several, small, or few but large
fissures
1
Total degeneration of grafted area 0
Overall repair assessment (max. 12 points)
Grade I: normal 12
Grade II: nearly normal 11–8
Grade III: abnormal 7–4
Grade IV: severely abnormal 3–1
JOURNAL OF ORTHOPAEDIC RESEARCH DECEMBER 2010
Dissertation   Jeremy S. Somerson 
 
 
 
18  
TRIPHASIC CONSTRUCT FOR OSTEOCHONDRAL REPAIR 1595
Table A3. ICRS Visual Histological Scale34
Points
I: Surface
Smooth/continuous 3
Discontinuities/irregularities 0
II: Matrix
Hyaline 3
Mixture: hyaline/fibrocartilage 2
Fibrocartilage 1
Fibrous tissue 0
III: Cell distribution
Columnar 3
Mixed/columnar-clusters 2
Clusters 1
Individual cells/disorganized 0
IV: Cell population viability
Predominantly viable 3
Partially viable 1
<10% viable 0
V: Subchondral bone
Normal 3
Increased remodeling 2
Bone necrosis/granulation tissue 1
Detached/fracture/callus at base 0
VI: Cartilage mineralization (calcified cartilage)
Normal 3
Abnormal/inappropriate location 0
Sum of points (max. 18 points)
system assesses (I) degree of defect repair (defect fill-
ing), (II) integration to border zone and (III) macroscopic
surface appearance.
Histological Analysis
The samples were dehydrated using progressive alcohol
concentrations and placed into light-curing embedding
resin (Technovit 7200 VLC, Heraeus Kulzer, Hanau,
Germany) for 2 days. Following this, infiltration with
embedding resin was performed for an additional 13
days with agitation under vacuum conditions. The sam-
ples were then placed into molds, which were filled
with embedding resin. Polymerization was performed
in two steps using a commercial polymerization device
(Histolux, Exakt Apparatebau GmbH). Treatment with
low light intensity was followed by a second stage
of high light intensity to complete the polymerization
process over a total time of 10h. The samples were
kept overnight in an incubator (Memmert, Schwabach,
Germany) before being cut and mounted onto slides.
The slides were then treated with toluidine blue31
and Levai–Laczko32,33 stains and finally graded inde-
pendently by three reviewers including a specialist
orthopedic surgeon and a musculoskeletal patholo-
gist using the ICRS Visual Histological Visual Scale
(Table A3),34 the O’Driscoll Scale (Table A4)35 and the
semiquantitative Siebert score (Table A5).36
Table A4. O’Driscoll Score35
Points
I: Nature of predominant tissue
(A) Cellular morphology
Hyaline articular cartilage 4
Incompletely differentiated
mesenchyme
2
Fibrous tissue or bone 0
(B) Safranin-O staining of the matrix
Normal or nearly normal 3
Moderate 2
Slight 1
None 0
II: Structural characteristics
(A) Surface regularity
Smooth and intact 3
Superficial horizontal lamination 2
Fissures: 25–100% of the
thickness
1
Severe disruption, including
fibrillation
0
(B) Structural integrity
Normal 2
Slight disruption, including cysts 1
Severe disintegration 0
(C) Thickness
100% of normal adjacent
cartilage
2
50–100% of normal cartilage 1
0–50% of normal cartilage 0
(D) Bonding to the adjacent cartilage
Bonded at both ends of graft 2
Bonded at one end, or partially
at both ends
1
Not bonded 0
III: Freedom from cellular changes of degeneration
(A) Hypocellularity
Normal cellularity 3
Slight hypocellularity 2
Moderate hypocellularity 1
Severe hypocellularity 0
(B) Chondrocyte clustering
No clusters 2
<25% of the cells 1
25–100% of the cells 0
IV: Freedom from degenerative changes in adjacent
cartilage
Normal cellularity, no clusters,
normal staining
3
Normal cellularity, mild clusters,
moderate staining
2
Mild or moderate hypocellularity,
slight staining
1
Severe hypocellularity, poor or no
staining
0
Sum of points (max. 24 points)
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Table A5. Semiquantitative Siebert Score36
Points
(A) Surface characteristics
Smooth 2
Somewhat irregular 1
Irregular 0
(B) Cartilage thickness
76–100% of the surrounding
cartilage
4
51–75% 3
26–50% 2
<25% 1
0% (defect) 0
(C) Bonding
Apposition of both contact surfaces 2
One surface 1
No bonding 0
(D) Subchondral reconstruction
Even with surrounding bone 4
Slightly offset (25%) 3
Moderately offset (50%) 2
Significantly offset (75%) 1
No reconstruction/formation 0
(E) Cartilage gap
No gap 4
Gap up to 25% of the transplanted
cartilage thickness
3
26–50% 2
51–75% 1
76–100% 0
Sum of points (max. 16 points)
Biomechanical Testing
Prior to histological analysis, the cut sample cylinders
underwent biomechanical analysis with a ball inden-
tation test. An area near the center of the defect was
used for testing to avoid a boundary effect. In addition,
samples of native cartilage from the lateral condyle of
the right femur of each animal were tested for compar-
ison. The samples were held uniaxially in a ring clamp.
To obtain near-physiological conditions, the clamp was
mounted in a transparent PMMA tank filled with PBS
at a pH of 7.4. The tank was mounted onto a two-
dimensional miniature electromechanical goniometer
Figure B2. Time course of gene expression of Sox9, aggrecan,
collagen 2A1 (transcription variants 1 and 2), chondroadherin
and link protein in collagen-I-hydrogel cultures measured by RT-
PCR. Expression levels were normalized to the housekeeping gene
GAPDH. Lane 1: monolayer culture of P1; lanes 2–4: gel cultures
of days 1, 7, and 14.
stage, which was in turn mounted onto a linear X, Y
stage. This setup allowed for amaximum load of 40N. To
evaluate themechanical properties of the samples, a ball
indentation test was used with a ISO 14577-2 compat-
ible setup. A steel ball (X105CrMo17) with a diameter
of 1mm and a Young’s modulus of 215×103 N/mm2 was
used. A displacement-controlled regime was performed
with a loading/unloading velocity of 10!m/s and a max-
imum depth indentation of 200!m. The indentation
depths of 200!mwere determined in a preliminary test
on untreated native knee joins as the optimum between
substrate influence from the bone tissue and the contact
problem.
Figure B1. Viability, distribution, morphology of MSCs in the chondral (A and C) and osseous (B and D) phases after 14 days in vitro.
Fluorescence images of live (green) and dead (red) MSCs in the respective scaffolds as determined by fluorometric viability assay (A and
B 1,000!m bar). Scanning electron microscopy images showing typical cell distribution and morphology of MSCs (white arrows) in the
chondral and osseous material (black arrows) (C and D 30!m bar).
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Figure B3. Immunohistochemical detection of aggrecan (A and B) and collagen type II (C and D) in collagen-I hydrogel cultures (50×,
200!mbar). One day after gel preparation no aggrecan staining was visible (A). Fourteen days after chondrogenic differentiation strongly
positive staining of aggrecan through the entire construct was evident (B). Similar to this result, no collagen type II was evident at day
1 (C) but was observed at day 14 (D).
Pre-testing contact force was 2mN. During the way-
controlled experiment the force and travel distance were
measured independently by a load cell and a inductive
displacement sensor.
In relation to the relative varied morphology and
thickness of different tissues layer the measured force
values were influenced by these and represent a
mixed/averaged value.
APPENDIX B
Viability, Distribution, and Morphology of Embedded Cells
Primary ovine MSCs from P1 were mixed with both the
collagen I hydrogel for the chondral phase and the autol-
ogous plasma for seeding onto the "-TCP-cylinder for
the osseous phase. Both constructs were cultivated for
2 weeks, combined with autologous plasma and later
implanted into the osteochondral defect site. Overall cell
viability, distribution andmorphology were determined.
As represented in Figure B1A and B, both types of scaf-
folds showed a high cell viability of ∼95% after 2 weeks
of 3D cultivation. Fluorescence microscopy of the MSC
collagen gels (Fig. B1A) demonstrated a high density of
living MSCs and few dead cells within the gel. Fluores-
cence staining with a live/dead kit was also performed
14 days after seeding and cultivation of theMSC-plasma
suspension onto "-TCP cylinders. This showed similar
results to microscopy with a homogeneous distribution
of livingMSCs and few dead cells. Cross-sectional imag-
ing of both MSC-seeded matrices by SEM analysis prior
to implantation showed the characteristic microstruc-
ture of both biomaterials, the compact collagen fibers
(Fig. B1C) and the fibrin fibrillar structure (Fig. B1D).
Both images illustrate the integration of MSCs into the
respective framework with a typical dense cell occur-
rence in the peripheral zones. Horizontally oriented cell
layers of MSCs with fibroblastic morphology were seen
covering both biomaterials.
Accumulation and Expression of Cartilage-Specific
Extracellular Matrix Markers
RT-PCR
Chondrogenic differentiation of the cartilage phase was
analyzed using reverse transcriptase polymerase chain
reaction (RT-PCR) (Fig. B2) and immunohistochemistry
(Fig. B3). In themonolayer culture (Fig. B2, lane 1) there
was no significant expression of the analyzed genes,
except for weak expression of the early, immature splice
variant of collagen 2A1, the transcription variant 1. Col-
lagen 1A1, which is expressed constitutively by MSCs,
was found at constant levels during 3D cultivation.
In contrast, at the time of implantation (day 14), the
MSC gels were demonstrated to express mRNA of the
genes Sox9, aggrecan, chondroadherin, and link protein,
which represent important markers of chondrogenesis
(Fig. B2, lane 4).
The constructs also showed expression of the mature
splice variant of collagen 2A1, transcription variant 2,
which is known to be expressed in a later stage of chon-
drogenesis and which is encoded for the major solid
component matrix protein of hyaline cartilage. Thus,
these results suggest progression of chondrogenic dif-
ferentiation.
Immunohistochemistry
Chondrogenesis of MSCs at the protein level was exam-
ined by immunostaining for proteoglycan aggrecan and
hyaline cartilage specific collagen type II after gel
preparation (Fig. B3A and B) and prior to implanta-
tion (Fig. B3C and D). After 1 day the cryosections
of the gels showed no evidence of these major car-
tilage matrix markers. In contrast, the accumulation
of aggrecan and collagen type II were evident after
14 days in the MSC hydrogels cultured under chon-
drogenic conditions, as demonstrated by the strong
positive immunostaining. The immunohistochemical
results showed a pronounced, strongly positive intert-
erritorial staining of aggrecan throughout the entire
construct, whereas collagen type II showed a distinct but
not uniform distribution of staining within the hydro-
gels. These findings at the protein level in the MSC gels
provide additional evidence of chondrogesis.
REFERENCES
1. Shelbourne KD, Jari S, Gray T. 2003. Outcome of untreated
traumatic articular cartilage defects of the knee: A natural
history study. J Bone Joint Surg Am 85-A(Suppl. 2):8–16.
2. Gudas R, Kalesinskas RJ, Kimtys V, et al. 2005. A prospec-
tive randomized clinical study of mosaic osteochondral
autologous transplantation versus microfracture for the
treatment of osteochondral defects in the knee joint in young
athletes. Arthroscopy 21:1066–1075.
JOURNAL OF ORTHOPAEDIC RESEARCH DECEMBER 2010
Dissertation   Jeremy S. Somerson 
 
 
 
21 
 
1598 MARQUASS ET AL.
3. Hangody L, Fu¨les P. 2003. Autologous osteochondral
mosaicplasty for the treatment of full-thickness defects of
weight-bearing joints: Ten years of experimental and clinical
experience. J Bone Joint Surg Am 85-A (Suppl. 2):25–32.
4. Hangody L, Va´sa´rhelyi G, Hangody LR, et al. 2008. Autol-
ogous osteochondral grafting—Technique and long-term
results. Injury 39 (Suppl. 1):S32–S39.
5. LaPrade RF, Botker JC. 2004. Donor-site morbidity after
osteochondral autograft transfer procedures. Arthroscopy
20:69–73.
6. Reddy S, Pedowitz DI, Parekh SG, et al. 2007. The morbidity
associated with osteochondral harvest from asymptomatic
knees for the treatment of osteochondral lesions of the talus.
Am J Sports Med 35:80–85.
7. Paul J, Sagstetter A, Kriner M, et al. 2009. Donor-site mor-
bidity after osteochondral autologous transplantation for
lesions of the talus. J Bone Joint Surg Am 91:1683–1688.
8. Iwasaki N, Kato H, Kamishima T, et al. . Donor site
evaluation after autologous osteochondral mosaicplasty for
cartilaginous lesions of the elbow joint. Am J Sports Med
35:2096–2100.
9. Jackson DW, Scheer MJ, Simon TM. 2001. Cartilage substi-
tutes: Overview of basic science and treatment options. J Am
Acad Orthop Surg 9:37–52.
10. Rose T, Craatz S, Hepp P, et al. 2005. The autologous
osteochondral transplantation of the knee: Clinical results,
radiographic findings and histological aspects. Arch Orthop
Trauma Surg 125:628–637.
11. Horas U, Pelinkovic D, Herr G, et al. 2003. Autologous
chondrocyte implantation and osteochondral cylinder trans-
plantation in cartilage repair of the knee joint. A prospective,
comparative trial. J Bone Joint Surg Am 85-A:185–192.
12. Lane J, Massie J, Ball S, et al. 2004. Follow-up of osteochon-
dral plug transfers in a goat model: A 6-month study. Am J
Sports Med 32:1440–1450.
13. Keeney M, Pandit A. 2009. The osteochondral junction and
its repair via bi-phasic tissue engineering scaffolds. Tissue
Eng Part B Rev 15:55–73.
14. Hung CT, Lima EG, Mauck RL, et al. 2003. Anatomi-
cally shaped osteochondral constructs for articular cartilage
repair. J Biomech 36:1853–1864.
15. Oliveira JM, Rodrigues MT, Silva SS, et al. 2006. Novel
hydroxyapatite/chitosan bilayered scaffold for osteochondral
tissue-engineering applications: Scaffold design and its per-
formance when seeded with goat bone marrow stromal cells.
Biomaterials 27:6123–6137.
16. Sherwood JK, Riley SL, Palazzolo R, et al. 2002. A three-
dimensional osteochondral composite scaffold for articular
cartilage repair. Biomaterials 23:4739–4751.
17. Ahn J-H, Lee T-H, Oh J-S, et al. 2009. A novel hyaluronate-
atelocollagen/beta-TCP-hydroxyapatite biphasic scaffold for
the repair of osteochondral defects in rabbits. Tissue Eng
Part A 15:2596–2604.
18. Alhadlaq A, Mao JJ. 2005. Tissue-engineered osteochondral
constructs in the shape of an articular condyle. J Bone Joint
Surg Am 87:936–944.
19. Frenkel SR, Toolan B, Menche D, et al. 1997. Chondrocyte
transplantation using a collagen bilayer matrix for cartilage
repair. J Bone Joint Surg Br 79:831–836.
20. Gao J, Dennis JE, Solchaga LA, et al. 2002. Repair of osteo-
chondral defect with tissue-engineered two-phase composite
material of injectable calcium phosphate and hyaluronan
sponge. Tissue Eng 8:827–837.
21. Kandel R, Grynpas M, Pilliar R, et al. 2006. Repair
of osteochondral defects with biphasic cartilage-calcium
polyphosphate constructs in a sheep model. Biomaterials
27:4120–4131.
22. HeppP,OsterhoffG,NiederhagenM, et al. 2009. Perilesional
changes of focal osteochondral defects in an ovine model
and their relevance to human osteochondral injuries. J Bone
Joint Surg Br 91:1110–1119.
23. Marquass B, Hepp P, Schmidt S, et al. 2009. Chondrogenic
predifferentiation of ovine mesenchymal stem cells leads to
a better histological repair of chronic osteochondral defects
after one year in a sheep model. In: Beger H, editor. Pro-
ceedings of the 13th Annual Meeting on Surgical Research
in Langenbecks Arch Surg, Vol. 394. Munich, Germany:
Springer Berlin/Heidelberg; p 915–970.
24. Alhadlaq A, Elisseeff JH, Hong L, et al. 2004. Adult stem
cell driven genesis of human-shaped articular condyle. Ann
Biomed Eng 32:911–923.
25. Cao T, Ho K-H, Teoh S-H. 2003. Scaffold design and in
vitro study of osteochondral coculture in a three-dimensional
porous polycaprolactone scaffold fabricated by fused deposi-
tion modeling. Tissue Eng 9 (Suppl. 1):S103–S112.
26. ChenG, Sato T, Tanaka J, et al. 2006. Preparation of a bipha-
sic scaffold for osteochondral tissue engineering. Mater Sci
Eng C26:118–123.
27. Chen G, Tanaka J, Tateishi T. 2006. Osteochondral tissue
engineering using a PLGA-collagen hybrid mesh. Mater Sci
Eng C26:124–129.
28. Shao XX, Hutmacher DW, Ho ST, et al. 2006. Evaluation of
a hybrid scaffold/cell construct in repair of high-load-bearing
osteochondral defects in rabbits. Biomaterials 27:1071–1080.
29. Brittberg M, Peterson L. 1998. Introduction to an articular
cartilage classification. ICRS Newsl 1:8.
30. Peterson L, Minas T, Brittberg M, et al. 2000. Two- to 9-year
outcome after autologous chondrocyte transplantation of the
knee. Clin Orthop Relat Res 374:212–234.
31. Feder N, Wolf M. 1965. Studies on nucleic acid metachro-
masy: II. Metachromatic and orthochromatic staining by
toluidine blue of nucleic acids in tissue sections. J Cell Biol
27:327.
32. Laczko J, Levai G. 1975. A simple differential staining
method for semi-thin sections of ossifying cartilage and bone
tissues embedded in epoxy resin. Mikroskopie 31:4.
33. Donath K. 1988. Die trenn-du¨nnschliff-technik zur her-
stellung histologischer pra¨parate von nicht schneidbaren
geweben und materialien. Der Pra¨parator 34:197–206.
34. Mainil-Varlet P, Aigner T, Brittberg M, et al. 2003. Histolog-
ical assessment of cartilage repair: A report by the Histology
Endpoint Committee of the International Cartilage Repair
Society (ICRS). J Bone Joint Surg Am 85-A (Suppl. 2):45–57.
35. O’Driscoll SW, Keeley FW, Salter RB. 1988. Durability of
regenerated articular cartilage produced by free autoge-
nous periosteal grafts in major full-thickness defects in joint
surfaces under the influence of continuous passive motion.
A follow-up report at one year. J Bone Joint Surg Am
70:595–606.
36. Siebert CH, Miltner O, Weber M, et al. 2003. Healing of
osteochondral grafts in an ovine model under the influence
of bFGF. Arthroscopy 19:182–187.
37. Zscharnack M, Hepp P, Richter R, et al. 2010. Repair of
chronic osteochondral defects using pre-differentiated mes-
enchymal stem cells in an ovine model. Am J Sports Med (in
press).
38. Pei M, He F, Boyce B, et al. 2009. Repair of full-thickness
femoral condyle cartilage defects using allogeneic synovial
cell-engineered tissue constructs. Osteoarthritis Cartilage
17:714–722.
39. Uematsu K, Hattori K, Ishimoto Y, et al. 2005. Carti-
lage regeneration using mesenchymal stem cells and a
three-dimensional poly-lactic-glycolic acid (PLGA) scaffold.
Biomaterials 26:4273–4279.
JOURNAL OF ORTHOPAEDIC RESEARCH DECEMBER 2010
Dissertation   Jeremy S. Somerson 
 
 
 
22 
 
TRIPHASIC CONSTRUCT FOR OSTEOCHONDRAL REPAIR 1599
40. Petersen JP, Ueblacker P, Goepfert C, et al. 2008. Long term
results after implantation of tissue engineered cartilage for
the treatment of osteochondral lesions in a minipig model. J
Mater Sci Mater Med 19:2029–2038.
41. Bruder SP, Kurth AA, Shea M, et al. 1998. Bone regener-
ation by implantation of purified, culture-expanded human
mesenchymal stem cells. J Orthop Res 16:155–162.
42. Frosch KH, Drengk A, Krause P, et al. 2006. Stem cell-coated
titanium implants for the partial joint resurfacing of the
knee. Biomaterials 27:2542–2549.
43. Guo X,WangC, ZhangY, et al. 2004. Repair of large articular
cartilage defects with implants of autologous mesenchymal
stem cells seeded into beta-tricalcium phosphate in a sheep
model. Tissue Eng 10:1818–1829.
44. Stockwell RA. 1971. The interrelationship of cell density and
cartilage thickness inmammalian articular cartilage. J Anat
109:411–421.
45. Pulliainen O, Vasara A, Hyttinen M, et al. 2007. Poly-LD-
lactic acid scaffold in the repair of porcine knee cartilage
lesions. Tissue Eng 13:1347–1355.
46. Benazzo F, Cadossi M, Cavani F, et al. 2008. Cartilage repair
with osteochondral autografts in sheep: Effect of biophysical
stimulation with pulsed electromagnetic fields. J Orthop Res
26:631–642.
47. vonRechenbergB, AkensMK,NadlerD, et al. 2003. Changes
in subchondral bone in cartilage resurfacing—Anexperimen-
tal study in sheep using different types of osteochondral
grafts. Osteoarthritis Cartilage 11:265–277.
JOURNAL OF ORTHOPAEDIC RESEARCH DECEMBER 2010
Dissertation   Jeremy S. Somerson 
 
 
 
23 
3. Summary 
 
Cumulative dissertation for obtaining the academic title Dr. med. 
 
 
Mesenchymal Stem Cell Constructs for Repair of  
Focal Cartilage Defects in an Ovine Model 
 
 
Submitted by: Jeremy Samuel Somerson 
 
Completed at: Department of Orthopedics, Plastic Surgery and    
 Traumatology at the University Clinic of Leipzig  
 [Universität Leipzig, Klinik und Poliklinik für Orthopädie,  
 Unfallchirurgie und Plastische Chirurgie] 
 
Mentored by: Prof. Dr. Pierre Hepp 
 PD Dr. Bastian Marquass 
 Dr. rer. nat. Ronny Schulz 
 
Submitted in: December 2015 
 
 
Background: The treatment of FCDs remains a problem for orthopaedic surgeons given 
the disadvantages of current methods. In the absence of treatment, focal lesions will 
continue to degenerate and result in OA. Techniques for transplanting native osteochondral 
tissue into defect areas have been described in the literature under the names 
osteochondral autograft transfer (OAT) or mosaicplasty. These methods have been 
successful, but result in morbidity at the donor site that limits the amount of tissue that can 
be harvested. Further, bonding of the grafts to surrounding tissue has been inadequate in 
some cases based on clinical and animal testing. Use of a synthetic multiphasic implant 
seeded with multipotent MSCs has the promise to provide similar repair qualities without 
the limitations of donor site morbidity.  
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Aims: The goal of this work was to determine whether repair of critical-size chronic FCDs 
using MSC-seeded triphasic constructs would provide similar repair qualities as OAT in a 
large animal model at six and twelve months. 
 
Method and Results: Ten female merino sheep were randomized into groups of 6-month 
and 12-month follow-up at the beginning of this trial (see Figure 4). Each sheep underwent 
a primary surgery in which both stifle joints were arthrotomized and a 4-mm diameter 
defect extending 2 mm below the calcified layer was created in the medial femoral 
condyles.  
Figure 4: Flow chart for the controlled laboratory trial. 
  
Bilateral focal cartilage defects created in 
stifle joints of ten sheep (n=20)
Defects allowed to degenerate for six weeks
Left stifle treated with 
osteochondral autograft 
(n=10); randomized to 6 
and 12 month groups
Defects evaluated at 
6 months after 
implantation (n=5)
Defects evaluated at 
12 months after 
implantation (n=5)
Right stifle treated with 
triphasic scaffold 
(n=10); randomized to 6 
and 12 month groups
Defects evaluated at 
6 months after 
implantation (n=5)
Defects evaluated at 
12 months after 
implantation (n=5)
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At the time of surgery, bone marrow was aspirated for culture of MSCs. The animals were 
then given a six-week period to allow the defects to degenerate. Following this, each 
animal underwent a second surgery in which the defects were cored out using a 6.4-mm 
cylindrical drill. The right stifle joint was treated with an osteochondral autograft taken from 
the non-weight-bearing portion of the trochlea, which was press fit into the defect zone. The 
left stifle joint was treated with a synthetic, tissue-engineered construct. The osseous layer 
was made using a commercially-available TCP cylinder (CERASORB, Curasan, 
Kleinostheim, Germany) that was seeded with 1 x 106 MSCs. The cartilage layer was 
created by seeding a collagen type I hydrogel (CaReS, Arthro Kinetics Biotechnology, 
Krems, Austria) with 4 x 105 MSCs and culturing the construct in a chondrogenic medium 
mixed with 10 ng/ml transforming growth factor-beta. The osseous cylinders were 
implanted into the defect, followed by an autologous activated plasma phase and the 
cartilage phase.  
Sheep were sacrificed at 6 or 12 months and the tissue was assessed using macroscopic 
evaluation (ICRS Brittberg score), histological evaluation (ICRS-1 Visual Histological Scale, 
O’Driscoll score and Siebert Semiquantitative Score). Biomechanical testing was 
performed to determine the force required to make a standardized indentation in each 
group. Micro-CT scans were performed to evaluate the resorption and placement of the 
triphasic implants at latest follow-up. 
Macroscopic evaluation of the defects at 6 and 12 months showed no significant 
differences based on the ICRS Brittberg score. Microscopic analysis using the ICRS-1 
Visual Histological Scale (ICRS-VHS1), the O’Driscoll score and the Siebert 
Semiquantitative Score also showed no differences at 6 or 12 months in overall score. A 
significantly better score was seen in the subcategories for “matrix composition”, “cell 
distribution” and “cell population” in the OAT group at 12 months using the ICRS-VHS1 
score, while the “bonding to adjacent cartilage” O’Driscoll subscore was higher in the 
triphasic group at 6 months. Biomechanical indentation testing showed no significant 
differences in softness between the two test groups or native cartilage at 12 months. 
Radiographic testing showed that four of the ten osseous phase implants subsided to 3 mm 
or more below the subchondral bone plate. 
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Discussion: Treatment with a tissue-engineered triphasic implant showed comparable 
histological repair qualities to osteochondral allograft transfer in a sheep model of chronic 
FCDs at 6 and 12 months. The evidence of superior bonding to adjacent cartilage tissue in 
the 6 month groups was encouraging. However, the sinking of 4 of 10 of the osseous 
phase implants below the subchondral surface is cause for concern. The authors surmised 
that the sinking phenomenon was due to the relative softness of the femoral cancellous 
bone relative to the harder TCP cylinders, as has been reported in other studies. Although 
the proof of concept is considered successful, given the differentiated growth of cartilage 
and bone layers from an MSC-seeded graft, further study is needed to investigate superior 
fixation of the osseous phase into bone. 
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